ABSTRACT SUBMISSION GUIDELINES

Deadline: 11:59pm, Monday 20 April 2026

The theme for ASID CRN 2026 Meeting is, ‘Excellence in Research, Equity in Impact’. Abstract and author details must be submitted online using the ASID CRN 2026 Abstract Submission Portal.

For your presentation to be considered, these abstract guidelines must be followed. Please ensure that the presenting author completes the abstract submission. Abstracts must be submitted by 11:59pm, Monday 20 April 2026, Australian Eastern Standard Time.

Early career researchers, trainees, current PhD students up to 5 years from completing their PhD will be given preference.

Please ensure you have read the guidelines and information below before submitting your abstract.

Submit an Abstract

Presentation Categories:

There will be two abstract presentation sessions and authors are welcome to submit abstracts for either of these sessions. You will be asked to indicate which session your abstract fits into during the submission process.

The Lightning Abstract Session is designed for the presentation of new research findings, whether arising from a completed or ongoing research project or clinical trial. This session provides investigators with the opportunity to share fresh data, key results, or emerging insights with the CRN community. Abstracts submitted to this stream should focus on the generation of new knowledge—highlighting study outcomes, methodological innovations, or clinically relevant discoveries—and will be delivered in a concise, fast paced presentation format.

The Project Pitch Session invites abstracts describing a proposed, planned, or already approved study protocol. This session aims to support investigators who are in the design or early implementation phases of a project and are seeking broader engagement. Presenters will “pitch” their protocol to the audience with the goal of either recruiting additional study sites or receiving constructive feedback and advice on their trial or project design. This session encourages collaboration, peer input, and cross network support to strengthen research efforts across the CRN.

ABSTRACT GUIDELINES

Abstracts should be thoroughly checked for spelling and grammar.
No editing will be conducted on behalf of authors and abstracts will be published as submitted. Edits to abstracts will not be permitted after submissions have closed.
An abstract must be submitted by the presenting author and only the presenting author’s contact details should be used in the submission form
Abstracts must be prepared in accordance with the guidelines below
The panel will shortlist abstracts that are suitable for a 15-minute oral presentation.
Oral presentations will be judged by a panel of CRN 2026 committee members during the conference. There will be prizes for the best presentations in both categories.
By submitting an abstract, the author automatically allows ASID to publish their abstract on the ASID website in the members area and in any format appropriate for the delivery of the program for the meeting.

All abstracts must:

Be prepared in Arial 11-point type only
Single spacing should be used
Specify all abbreviations in full at the first mention, followed by the abbreviation in parentheses, thereafter abbreviation only should be used
Abstracts must be original and written in English
Abstracts must NOT have a header or footer on the page
Do not include references

All abstracts must include:

TITLE should appear in BOLD CAPITALS
Principal author to appear first
Underline the name of the author who will be presenting the paper
Use surname followed by initials with no punctuation (do not use full stops or commas between surname and initials e.g. Smith AB, Jones J, Chan L, McDonald W)
Omit degrees and titles
Include affiliations for each author. Use superscript numbering after the author’s name to indicate affiliations

Authors will be required to indicate if they are any of the following:

Trainee
PhD Student
Early career researcher
ASID member

Body of abstract:

Maximum length is 250 words excluding title (up to 20 words) and authors (excess words may not be printed)
Present your work as a structured abstract with the following Subheadings: Introduction, Methods, Results and Conclusions (if relevant)
A maximum of one figure or one table may be used
Note: If your abstract does not conform to the guidelines, including if it is over 250 words (plus max 20-word title), it will be returned to the submitting author to revise.

ALL ABSTRACTS MUST INCLUDE:

Disclosure of Interest Statement:

Example: “The Australasian Society for Infectious Diseases recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in

publications and presentations.”

Disclosure of interest statement – Industry:

Example 1. Organisation X declares payments to his institution for investigator-initiated research from Industry Company X.

Example 2. Organisation X has received donated materials from Industry Company X. All other authors declare no competing interests.

Acknowledgement of Funding

Example 1. This study was funded in part by the Government Body X.

Example 2. Organisation X receive grant funding from the Government Body X. No pharmaceutical / Industry grants were received for this study.

Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.

CONFERENCE REGISTRATION

Abstract presenting authors will be required to fund their own attendance at the conference.

All presenting authors will be required to register for the conference by the early bird date, 24 June 2026. Any presenter not registered will be removed from the program.